Fig. 4: Outcomes according to ELN-22 risk classification (above) and ICSA genetic groups (below).

For the latter the favorable group includes ELN-22 favorable-risk genetics and NPM1^mut/FLT3^low, the very adverse group refers to CK/MK/TP53alt/MECOMr and the intermediate group contains all other patients.